VOPROSY MEDITSINSKOI KHIMII (ISSN 0042-8809)

Hypermethylation of the human calcitonin gene as a molecular marker of acute lymphoblastic leukemia

   
Marinitch D.V.1, Uss A.L.1, Smirnova L.A.2, Vorobyev L.A.1, Holmes J.A.3, Sulimova G.E.4, Shevchuk T.V.5, Buryanov Y.I.5

1. Republican Center of Transplantation of Bone Marrow, Minsk, Byelorussian Republic
2. Byelorussian Medical Academy of Post-graduate Education, Minsk, Byelorussian Republic
3. Department of Transplantation of Bone Marrow, Queen Elizabeth Hospital, Birmingham, Great Britain
4. Vavilov Institute of General Genetics, Russian Academy of Sciences
5. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Pushchino Branch, Russian Academy of Sciences
PubMed Id: 11766265
Year: 2001  Volume: 47  Issue: 5  Pages: 537-546
HpaII/MspI blot-hybridization analysis of the 5'-end region of the calcitonin (CT) gene methylation in cells of bone marrow and peripheral blood of patients with acute lymphoblastic leukemias (ALL) has been carried out. ALLs are accompanied by hypermethylation of the inner cytosine in the CCGG sequences of this region of the CT gene. The level of hypermethylation of the CT gene corresponded to the degree of disease progression and malignancy. At a long-term remission, hypermethylation of the CT gene is not observed. In case of primary resistance or if the complete remission has not been achived the CT gene remained hypermethylated. It has been shown that in relapse the normal CT gene methylation pattern reversed to hypermethylation. This phenomenon was detected 1-8 months before the obvious clinical and laboratory signs of the disease progression (relapse). The large size of abnormal HpaII-fragments of the 5'-end region of the calcitonin gene had a direct correlation with the malignancy status of ALL
Download PDF:  
Citation:

Marinitch, D. V., Uss, A. L., Smirnova, L. A., Vorobyev, L. A., Holmes, J. A., Sulimova, G. E., Shevchuk, T. V., Buryanov, Y. I. (2001). Hypermethylation of the human calcitonin gene as a molecular marker of acute lymphoblastic leukemia. Voprosy Meditsinskoi Khimii, 47(5), 537-546.
References  
 2002 (vol 48)
 2001 (vol 47)
 2000 (vol 46)
 1999 (vol 45)
 1998 (vol 44)
 1997 (vol 43)
 1996 (vol 42)
 1995 (vol 41)
 1994 (vol 40)
 1993 (vol 39)
 1992 (vol 38)
 1991 (vol 37)
 1990 (vol 36)
 1989 (vol 35)
 1988 (vol 34)
 1987 (vol 33)
 1986 (vol 32)
 1985 (vol 31)